NADDI is a non-profit organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the prevention and investigation of prescription drug diversion. NADDI's objective is to improve its members' ability to investigate and prosecute pharmaceutical drug diversion.
This partnership provides NADDI members access to DSS's AuthentiSuite technologies as part of an initiative to standardize prescription drug authentication for members and customers. NADDI members have never before had access to this type of authentication capability. The AuthentiSite technology can be employed as a tool for investigators or consumers who are looking to verify websites for prescription drug purchases and validate that pharmaceutical product information, lists of authorized suppliers, and other online information comes from the Brand Owner and not an unauthorized or fraudulent source.
AuthentiSite provides true website authentication from a smartphone application. The DSS team will create and distribute an AuthentiSite seal equipped with DSS patented AuthentiGuard® PrismTMtechnology for NADDI and its members to implement on their websites. Using the smartphone application, investigators and consumers alike can scan the seal to verify that a website represents a true, licensed reseller.
Robert Bzdick, President of DSS stated, "We are pleased to be working with NADDI, the nation's most prominent organization linking healthcare regulators, manufacturers and consumers, to offer its members access to our AuthentiSite technology in order to combat drug diversion. This partnership brings the powerhouse of AuthentiSuite technologies into the pharmaceutical world, while opening up future opportunities to build business relationships in this area."